for intracellular pathogens, the host cell provides needed protection and nutrients. A major challenge of intracellular parasite research is collection of high parasite numbers separated from host contamination. This situation is exemplified by the malaria parasite, which spends a substantial part of its life cycle inside erythrocytes as rings, trophozoites, and schizonts, before egress and reinvasion. erythrocytic Plasmodium parasite forms refractory to enrichment remain understudied due to high host contamination relative to low parasite numbers. Here, we present a method for separating all stages of Plasmodium-infected erythrocytes through lysis and removal of uninfected erythrocytes. The Streptolysin O-Percoll (SLOPE) method is effective on previously inaccessible forms, including circulating rings from malaria-infected patients and artemisinin-induced quiescent parasites. SLope can be used on multiple parasite species, under multiple media formulations, and lacks measurable impacts on parasite viability. We demonstrate erythrocyte membrane cholesterol levels modulate the preferential lysis of uninfected host cells by SLO, and therefore modulate the effectiveness of SLOPE. Targeted metabolomics of SLOPE-enriched ring stage samples confirms parasite-derived metabolites are increased and contaminating host material is reduced compared to non-enriched samples. Due to consumption of cholesterol by other intracellular bacteria and protozoa, SLope holds potential for improving research on organisms beyond Plasmodium. Malaria, caused by protozoan parasites of the Plasmodium genus, is a continuing threat to global health. A total of five Plasmodium species cause malaria in humans, with Plasmodium falciparum being responsible for the large majority of malaria morbidity and mortality 1. While the global malaria burden has decreased over the past decade, the emergence and spread of antimalarial resistant Plasmodium threatens to undo this progress and emphasizes the dire need to understand more about the biology of this parasite. The current World Health Organization recommendation for treatment of malaria is artemisinin combination therapy 2. However, clinical resistance has now been reported to both artemisinin and almost all of its partner drugs 3-5. All symptoms of malaria, including cyclical fevers and hypoglycemia, occur due to the asexual replication cycle of the parasite within human erythrocytes (Fig. 1a). Parasites undergo rounds of replication progressing from the ring stage, to trophozoites and schizonts, before rupturing from host erythrocytes to release merozoites, which go on to invade new erythrocytes and continue the cycle of infection 6. Many studies aiming to understand the biology of asexual Plasmodium are performed only on late stage parasite samples (trophozoites and schizonts). This is due in part to the larger biomass of these stages but also to the existence of effective enrichment methods 7 ; erythrocytes infected with late stage parasites can be separated from uninfected erythrocytes by density...